Y
Yixue Cao
Researcher at University of California, San Diego
Publications - 9
Citations - 5724
Yixue Cao is an academic researcher from University of California, San Diego. The author has contributed to research in topics: IκB kinase & Cyclin D1. The author has an hindex of 9, co-authored 9 publications receiving 5478 citations.
Papers
More filters
Journal ArticleDOI
NF-κB in cancer: from innocent bystander to major culprit
TL;DR: Recent evidence indicates that NF-κB and the signalling pathways that are involved in its activation are also important for tumour development.
Journal ArticleDOI
Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway
Uwe Senftleben,Yixue Cao,Gutian Xiao,Florian R. Greten,Gertraud Krähn,Giuseppina Bonizzi,Yi Chen,Yinling Hu,Abraham Fong,Shao Cong Sun,Michael Karin +10 more
TL;DR: It is shown that IKKα is required for B cell maturation, formation of secondary lymphoid organs, increased expression of certain NF-κB target genes, and processing of the NF-σκB2 (p100) precursor.
Journal ArticleDOI
The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways
Emmanuel Dejardin,Nathalie Droin,Mireille Delhase,Elvira Haas,Yixue Cao,Constantin Makris,Zhi-Wei Li,Michael Karin,Carl F. Ware,Douglas R. Green +9 more
TL;DR: The lymphotoxin-beta receptor (LTbetaR) plays critical roles in inflammation and lymphoid organogenesis through activation of NF-kappaB, which requires NIK and IKKalpha for activation and the induction by LTbetaR ligation of chemokines and cytokines involved in lymphoids organogenesis.
Journal ArticleDOI
IKKα Provides an Essential Link between RANK Signaling and Cyclin D1 Expression during Mammary Gland Development
Yixue Cao,Giuseppina Bonizzi,Tiffany N. Seagroves,Florian R. Greten,Randall S. Johnson,Emmett V. Schmidt,Michael Karin +6 more
TL;DR: IKKα is a critical intermediate in a pathway that controls mammary epithelial proliferation in response to RANK signaling via cyclin D1 through NF-κB activation.
Journal ArticleDOI
IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss
Maria Grazia Ruocco,Shin Maeda,Jin Mo Park,Toby Lawrence,Li-Chung Hsu,Yixue Cao,Georg Schett,Erwin F. Wagner,Michael Karin +8 more
TL;DR: IKKβ protects osteoclasts and their progenitors from tumor necrosis factor α–induced apoptosis, and its loss in hematopoietic cells prevents inflammation-induced bone loss.